- CORDIS - PROJECTS 23/10/2009
Most nutraceutical SMEs have a limited access to the information needed for identifying the impact of their product at nutritional level. Also, the need of more personalized diets is an urgent requirement of EU healthcare systems, particularly for ageing and elderly people(EP). Nutraceuticals have different constraints not homogeneously defined in the EU Member States(MS)and their efficacy is always subordinate to the quality of the usual diet in different cultural scenarios. As a result, nutraceuticals are difficult to customize upon the needs of a specific market user, such as the EP, and their market is quite slow and fragmented.
In response to these challenges, the goal of RISTOMED is to develop a new e-Health service for EP that will enable participant SMEs to penetrate the EP consumers market with the production of an innovative diet model. Biotech nutraceuticals, specifically designed and efficaciously delivered to the EP, will be integrated in biotech/ICT strategies coping with the complexity of nutritional specific requirements. RISTOMED brings together 8 partners distributed in 5 countries with a good balance between SMEs and RTDPs. In RISTOMED 3 biotech SMEs will collaborate with 4 RTDPs to solve the common problem of delivering innovative nutraceuticals for the control and prevention of the age-related diseases throughout new E-Health services.
These services consist in the delivery of recipes and procedures containing nutraceuticals and probiotics specifically designed for EP and institutions dealing with EP throughout a new IT RISTOMED web platform (RWP).RWP will be developed by the ICT SME leading the consortium. The project result is expected to have a significant impact on the competitiveness of SME participants that will be able to expand their business by proposing to the market not only nutraceuticals but an integrated solution to better manage the diet and nutritional needs of EP to contrast inflammation, oxidative stress and gut microbiota alteration.
Start date: 2008-11-01
End date: 2010-10-31
Duration: 24 months
Project Reference: 222230
Project cost: 1.3 million euro
Project Funding: 969406.00 euro
Subprogramme Area: SME-1 Research for SMEs
Contract type: Research for SMEs
Coordinatore: VOX NET SOCIETA COOPERATIVA - ITALY - BUCCOLINI, Fabio (Mr)
- LA MAISON DE L 'ARGAN - FRANCE
- ACTIAL-FARMACEUTICA LDA - PORTUGAL
- AISA THERAPEUTICS - FRANCE
- CENTRE HOSPITALIER ET UNIVERSITAIRE DE BORDEAUX - FRANCE
- UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA - ITALY
- ALMA MATER STUDIORUM-UNIVERSITA DI BOLOGNA - ITALY
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN - GERMANY
Iscriviti alla newsletter gratuita per ricevere, 1 volta a settimana, news personalizzate negli ambiti di tuo interesse su bandi, eventi, ricerche partner e molto altro in materia di ricerca e innovazione.
In questo modo, avrai anche accesso a MY FIRST, l’area riservata dove potrai trovare salvate le tue ricerche e le news di tuo interesse
|Quadro di finanziamento||
|Area di interesse||